uniQure Ownership | Who Owns uniQure?
uniQure Ownership Summary
uniQure is owned by 64.52% institutional investors, 5.33% insiders, and 30.15% retail investors. Fmr is the largest institutional shareholder, holding 11.06% of QURE shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 5.26% of its assets in uniQure shares.
QURE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | uniQure | 64.52% | 5.33% | 30.15% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 6.06M | 11.06% | $353.70M |
| Avoro capital advisors | 4.44M | 8.11% | $259.42M |
| Rtw investments, lp | 4.42M | 8.07% | $258.29M |
| Ecor1 capital | 3.99M | 7.28% | $232.84M |
| Abrdn | 3.68M | 6.29% | $88.03M |
| Jpmorgan chase | 2.93M | 5.01% | $70.23M |
| Blackrock | 1.93M | 3.98% | $8.63M |
| Blackrock funding, inc. /de | 1.97M | 3.38% | $47.26M |
| State street | 1.44M | 2.63% | $84.29M |
| Fred alger management | 1.29M | 2.35% | $75.32M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital management | 800.00K | 14.88% | $46.70M |
| Ecor1 capital | 3.99M | 11.17% | $232.84M |
| Stempoint capital lp | 522.15K | 6.11% | $30.48M |
| Artia global partners lp | 658.84K | 6.09% | $38.46M |
| Eversept partners, lp | 877.37K | 3.53% | $51.21M |
| Birchview capital, lp | 78.73K | 3.47% | $4.60M |
| Avoro capital advisors | 4.44M | 3.35% | $259.42M |
| 683 capital management | 1.07M | 3.26% | $62.46M |
| Rtw investments, lp | 4.42M | 3.18% | $258.29M |
| Catalio capital management, lp | 282.94K | 3.05% | $16.52M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 6.06M | 0.02% | 4.88M |
| Jpmorgan chase | 2.93M | 0.00% | 1.79M |
| Fred alger management | 1.29M | 0.29% | 1.29M |
| Price t rowe associates inc /md/ | 913.18K | 0.01% | 913.18K |
| Eversept partners, lp | 877.37K | 3.53% | 877.37K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 225.00K | 0.59% | -3.48M |
| Sofinnova investments | 136.86K | 0.44% | -1.42M |
| Franklin resources | 746.60K | 0.00% | -1.24M |
| Integral health asset management | 600.00K | 2.37% | -750.00K |
| Rtw investments, lp | 4.42M | 3.18% | -733.26K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Fred alger management | 1.29M | 0.29% | 1.29M | $75.32M |
| Price t rowe associates inc /md/ | 913.18K | 0.01% | 913.18K | $53.30M |
| Eversept partners, lp | 877.37K | 3.53% | 877.37K | $51.21M |
| Fiera capital | 768.51K | 0.06% | 768.51K | $18.39M |
| Artia global partners lp | 658.84K | 6.09% | 658.84K | $38.46M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -19.00 |
| Nelson, van denburg & campbell wealth management group | -32.00 |
| Pineridge advisors | -38.00 |
| Bellevue asset management | -46.00 |
| Physician wealth advisors | -47.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 175 | -32.17% | 37,757,618 | -31.79% | 64 | 0.72% | 97 | -36.60% | 43 | -31.75% |
| Sep 30, 2025 | 253 | 45.40% | 55,350,112 | 4.51% | 100 | 1.08% | 150 | 105.48% | 61 | 7.02% |
| Jun 30, 2025 | 170 | 3.66% | 52,946,969 | 5.89% | 96 | 1.09% | 75 | 2.74% | 54 | 31.71% |
| Mar 31, 2025 | 23 | -85.35% | 19,779,316 | -52.46% | 37 | 0.51% | 14 | -81.08% | 5 | -89.36% |
| Dec 31, 2024 | 148 | 4.23% | 38,592,241 | -0.74% | 79 | 1.24% | 68 | -2.86% | 45 | 21.62% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 2.84M | 5.26% | -15.22K |
| abrdn Healthcare Investors | 1.52M | 2.80% | - |
| RTW Biotech Opportunities Ord | 1.39M | 2.57% | 1.39M |
| Fidelity Advisor Biotechnology I | 991.60K | 1.83% | 104.97K |
| abrdn World Healthcare | 987.82K | 1.83% | 48.33K |
| Fidelity Select Pharmaceuticals Port | 918.79K | 1.70% | 158.12K |
| Fidelity Select Health Care | 900.00K | 1.66% | - |
| SPDR® S&P Biotech ETF | 838.29K | 1.53% | 1.87K |
| Delaware Healthcare I | 706.17K | 1.45% | - |
| Macquarie Healthcare I | 706.17K | 1.29% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2026 | Kapusta Matthew C | CEO, Managing Director | Sell | $132.10K |
| Mar 04, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell | $7.32K |
| Mar 04, 2026 | Potts Jeannette | Chief Legal Officer | Sell | $30.91K |
| Mar 04, 2026 | KLEMT CHRISTIAN | Chief Financial Officer | Sell | $108.72K |
| Mar 02, 2026 | Kapusta Matthew C | CEO, Managing Director | Sell | $342.65K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 14 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | 9 |
| 2025 Q1 | - | 8 |
QURE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools